- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 24-38 of
231 results
3003 Exhibit: Ex 3003
Document
IPR2022-00853, No. 3003 Exhibit - Ex 3003 (P.T.A.B. Oct. 24, 2022)
|
|
Cite Document
3001 Exhibit: Ex 3001
Document
IPR2022-00853, No. 3001 Exhibit - Ex 3001 (P.T.A.B. Aug. 22, 2022)
|
|
Cite Document
2046 Exhibit: AAI Steinman Award for Human Immunology Research Past Recipien...
Document
IPR2022-00853, No. 2046 Exhibit - AAI Steinman Award for Human Immunology Research Past Recipients, AM ASS���N OF IMMUNOLOGISTS, httpswwwaaiorgAwardsCareer AwardsAAI Steinm...
|
|
Cite Document
2024 Exhibit: 2015 Watanabe Award Winner Carl H June, IND CLINICAL AND TRAN...
Document
IPR2022-00853, No. 2024 Exhibit - 2015 Watanabe Award Winner Carl H June, IND CLINICAL AND TRANSLATIONAL SCIS INST, httpsindianactsiorgawardswatanabe award winners2015 watana...
|
|
Cite Document
2040 Exhibit: ASH honors Bruce R Blazar, MD, and Carl H June, MD, with 2012 Ern...
Document
IPR2022-00853, No. 2040 Exhibit - ASH honors Bruce R Blazar, MD, and Carl H June, MD, with 2012 Ernest Beutler Lecture and Prize, SCIENCEX Aug 27, 2012, httpssciencexcomwire news107...
|
|
Cite Document
2023 Exhibit: Andrew Pollock, Setting the Body���s ���Serial Killers��� Loose on Canc...
Document
IPR2022-00853, No. 2023 Exhibit - Andrew Pollock, Setting the Body���s ���Serial Killers��� Loose on Cancer, NY TIMES Aug 1, 2016, httpswwwnytimescom20160802healthcancer cell therapy imm...
|
|
Cite Document
2003 Exhibit: Jasone Fagone, Walt Keller, Leukemia Survivor, Has Passed, PHILA ...
Document
IPR2022-00853, No. 2003 Exhibit - Jasone Fagone, Walt Keller, Leukemia Survivor, Has Passed, PHILA MAG Feb 20, 2014, httpswwwphillymagcomnews20140220walt keller leukemia survivor o...
|
|
Cite Document
2033 Exhibit: Richard A Morgan et al, Case Report of a Serious Adverse Event Follo...
Document
IPR2022-00853, No. 2033 Exhibit - Richard A Morgan et al, Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recogn...
|
|
Cite Document
2008 Exhibit: FOOD AND DRUG ADMIN, BREAKTHROUGH THERAPY Jan 4, 2018...
Document
IPR2022-00853, No. 2008 Exhibit - FOOD AND DRUG ADMIN, BREAKTHROUGH THERAPY Jan 4, 2018, httpswwwfdagovpatientsfast track breakthrough therapy accelerated approval priority re...
|
|
Cite Document
2009 Exhibit: FOOD AND DRUG ADMIN, PRIORITY REVIEW Jan 4, 2018, httpswww...
Document
IPR2022-00853, No. 2009 Exhibit - FOOD AND DRUG ADMIN, PRIORITY REVIEW Jan 4, 2018, httpswwwfdagovpatientsfast track breakthrough therapy accelerated approval priority reviewprior...
|
|
Cite Document
2018 Exhibit: David L Porter et al, Randomized, Phase II Dose Optimization Study O...
Document
IPR2022-00853, No. 2018 Exhibit - David L Porter et al, Randomized, Phase II Dose Optimization Study Of Chimeric Antigen Receptor Modified T Cells Directed Against CD 19 CTL019 In Patients...
|
|
Cite Document
2044 Exhibit: Adam Bagg Aff, July 19, 2022
Document
IPR2022-00853, No. 2044 Exhibit - Adam Bagg Aff, July 19, 2022 (P.T.A.B. Jul. 19, 2022)
|
|
Cite Document
2032 Exhibit: Michael C Jensen et al, Antitransgene Rejection Responses Contribu...
Document
IPR2022-00853, No. 2032 Exhibit - Michael C Jensen et al, Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20CD19 Specific Chimeric Anti...
|
|
Cite Document
2029 Exhibit: Pilot Study for Patients with Chemotherapy Resistant or Refractory C...
Document
IPR2022-00853, No. 2029 Exhibit - Pilot Study for Patients with Chemotherapy Resistant or Refractory CD19 Leukemia and Lymphoma CART 19, CLINICALTRIALSGOV April 29, 2009, httpweba...
|
|
Cite Document
2034 Exhibit: David L Porter et al, A phase 1 trial of donor lymphocyte infusions exp...
Document
IPR2022-00853, No. 2034 Exhibit - David L Porter et al, A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3CD28 costimulation, 107 BLOOD 1325 2006 (P.T.A....
|
|
Cite Document
